<p>Modera Wealth Management LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第二季度减少了对默克公司（NYSE:MRK - 免费报告）6.0% 的持股。该基金在季度内出售了 2,910 股后，持有该公司 45,255 股股票。到最近一个季度末，Modera Wealth Management LLC 在默克公司的持股价值为 3,582,000 美元。</p>
<p>获取 <strong>默克公司</strong> 的提醒：</p>
<ul>
<li>2 个理由说明 Absci 可能是 AI 生物技术的未来，以及 1 个风险</li>
</ul>
<p>其他大型投资者也调整了对该公司的持股。Peoples Financial Services CORP. 在第二季度将其在默克公司的股份增加了 0.5%。Peoples Financial Services CORP. 现在拥有 22,778 股该公司的股票，价值 1,803,000 美元，此前在上个季度增持了 122 股。McLean Asset Management Corp 在第二季度将其在默克公司的股份增加了 3.7%。McLean Asset Management Corp 现在拥有 3,543 股该公司的股票，价值 292,000 美元，此前在上个季度增持了 125 股。Cora Capital Advisors LLC 在第二季度将其在默克公司的股份增加了 2.4%。Cora Capital Advisors LLC 现在拥有 5,343 股该公司的股票，价值 423,000 美元，此前在上个季度增持了 125 股。Saiph Capital LLC 在第一季度将其在默克公司的股份增加了 3.7%。Saiph Capital LLC 现在拥有 3,565 股该公司的股票，价值 320,000 美元，此前在上个季度增持了 128 股。最后，Physician Wealth Advisors Inc. 在第二季度将其在默克公司的股份增加了 2.9%。Physician Wealth Advisors Inc. 现在拥有 4,587 股该公司的股票，价值 363,000 美元，此前在上个季度增持了 128 股。对冲基金和其他机构投资者持有该公司 76.07% 的股票。</p>
<h2>默克公司股票表现</h2>
<p>NYSE:MRK 周五开盘价为 86.34 美元。该公司的 50 日简单移动平均线为 84.59 美元，200 日简单移动平均线为 82.04 美元。该公司的速动比率为 1.17，流动比率为 1.42，债务与股本比率为 0.69。默克公司的 52 周低点为 73.31 美元，52 周高点为 105.07 美元。该公司的市值为 2156.6 亿美元，市盈率为 13.30，市盈增长比率为 0.95，贝塔值为 0.34。</p>
<ul>
<li>5 个医疗保健股票推动该行业的大反弹</li>
</ul>
<p>默克公司（NYSE:MRK - 获取免费报告）最近于 10 月 30 日（星期四）公布了季度财报。该公司报告每股收益（EPS）为 2.58 美元，超出市场共识预期的 2.36 美元，超出幅度为 0.22 美元。该公司在季度内的收入为 172.8 亿美元，而分析师预期为 170 亿美元。默克公司的股本回报率为 41.05%，净利润率为 25.79%。该公司的季度收入较去年同期增长了 3.7%。去年同期，该公司每股收益为 1.57 美元。默克公司已将其 2025 财年的指导目标设定为 8.930-8.980 每股收益。整体来看，股票分析师预计默克公司在当前财年将发布 9.01 美元的每股收益。</p>
<h2>华尔街分析师观点</h2>
<p>多家研究公司对 MRK 进行了评估。富国银行将默克公司的目标价从 97.00 美元下调至 90.00 美元，并在 7 月 30 日的研究报告中对该股票给予了 “持平” 的评级。Wall Street Zen 在周六的研究报告中将默克公司的股票评级从 “持有” 上调至 “强力买入”。花旗集团在 10 月 13 日的报告中对默克公司的股票进行了覆盖，给予 “中性” 评级，目标价为 95.00 美元。Weiss Ratings 在 10 月 8 日的研究报告中重申了对默克公司的 “持有（c-）” 评级。最后，Berenberg Bank 在 9 月 17 日的研究报告中将默克公司的股票评级从 “买入” 下调至 “持有”，并将目标价从 100.00 美元下调至 90.00 美元。一位股票研究分析师对该股票给予了强力买入评级，五位给予买入评级，十三位给予持有评级，一位给予卖出评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，平均目标价为 104.47 美元。</p>
<ul>
<li>随着市场轮动，这只医疗保健 ETF 引领潮流</li>
</ul>
<p><strong>查看我们最新的 MRK 股票报告</strong></p>
<h2>默克公司的内部买卖情况</h2>
<p>在其他消息中，执行副总裁 David Michael Williams 于 11 月 3 日（星期一）出售了 8,614 股该公司的股票。股票以平均价格 83.59 美元出售，总价值为 720,044.26 美元。出售后，该执行副总裁直接持有该公司 24,578 股股票，价值约为 2,054,475.02 美元。此次交易代表其持股减少了 25.95%。该交易已在向证券交易委员会提交的文件中披露，相关文件可通过此链接访问。内部人士持有该公司 0.13% 的股票。</p>
<h2>默克公司公司简介</h2>
<p>（免费报告）</p>
<p>默克公司是一家医疗保健公司，提供通过处方药、疫苗、生物治疗、动物健康和消费者护理产品的健康解决方案。它通过以下几个部门运营：制药、动物健康和其他。制药部门包括人类健康药品和疫苗产品。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，而不是默克公司。</li>
<li>三只具有高回报潜力的小型股</li>
<li>OpenAI 的重组可能会成为有史以来最大的 IPO</li>
<li>复利是如何计算的？</li>
<li>两只美国政府不希望失败的稀土股票</li>
<li>什么是特别股息？</li>
<li>CrowdStrike 与 CoreWeave 合作，但投资者抛售了消息</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1SSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1SSw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在默克公司吗？</h2>
<p>在考虑默克公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而默克公司并不在名单上。</p>
<p>虽然默克公司目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

默克

<p>Modera Wealth Management LLC 在第二季度减少了对默克公司（NYSE:MRK）6.0% 的持股，目前持有 45,255 股，价值 358 万美元。其他投资者也调整了他们的持股。默克的股票开盘价为 86.34 美元，市值为 2156.6 亿美元，市盈率为 13.30。公司报告第三季度每股收益为 2.58 美元，超出预期，收入为 172.8 亿美元。分析师对该股票的评级不一，目标价格范围在 90 美元到 95 美元之间</p>

<p>Modera Wealth Management LLC lessened its holdings in shares of Merck &amp; Co., Inc. (NYSE:MRK - Free Report) by 6.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The fund owned 45,255 shares of the company's stock after selling 2,910 shares during the quarter. Modera Wealth Management LLC's holdings in Merck &amp; Co., Inc. were worth $3,582,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Modera Wealth Management LLC 在最近向证券交易委员会提交的 13F 文件中表示，在第二季度减少了对默克公司（NYSE:MRK - 免费报告）6.0% 的持股。该基金在季度内出售了 2,910 股后，持有该公司 45,255 股股票。到最近一个季度末，Modera Wealth Management LLC 在默克公司的持股价值为 3,582,000 美元。</p>
</div><p>Get <strong>Merck &amp; Co., Inc.</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>默克公司</strong> 的提醒：</p>
</div><ul>
<li>2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk</li>
</ul>
<div class="lb-trans"><ul>
<li>2 个理由说明 Absci 可能是 AI 生物技术的未来，以及 1 个风险</li>
</ul>
</div><p>Other large investors have also modified their holdings of the company. Peoples Financial Services CORP. grew its stake in Merck &amp; Co., Inc. by 0.5% during the 2nd quarter. Peoples Financial Services CORP. now owns 22,778 shares of the company's stock valued at $1,803,000 after acquiring an additional 122 shares in the last quarter. McLean Asset Management Corp grew its position in shares of Merck &amp; Co., Inc. by 3.7% in the second quarter. McLean Asset Management Corp now owns 3,543 shares of the company's stock valued at $292,000 after purchasing an additional 125 shares in the last quarter. Cora Capital Advisors LLC increased its holdings in shares of Merck &amp; Co., Inc. by 2.4% in the second quarter. Cora Capital Advisors LLC now owns 5,343 shares of the company's stock valued at $423,000 after purchasing an additional 125 shares during the last quarter. Saiph Capital LLC increased its holdings in shares of Merck &amp; Co., Inc. by 3.7% in the first quarter. Saiph Capital LLC now owns 3,565 shares of the company's stock valued at $320,000 after purchasing an additional 128 shares during the last quarter. Finally, Physician Wealth Advisors Inc. lifted its position in Merck &amp; Co., Inc. by 2.9% during the second quarter. Physician Wealth Advisors Inc. now owns 4,587 shares of the company's stock worth $363,000 after buying an additional 128 shares in the last quarter. Hedge funds and other institutional investors own 76.07% of the company's stock.</p>
<div class="lb-trans"><p>其他大型投资者也调整了对该公司的持股。Peoples Financial Services CORP. 在第二季度将其在默克公司的股份增加了 0.5%。Peoples Financial Services CORP. 现在拥有 22,778 股该公司的股票，价值 1,803,000 美元，此前在上个季度增持了 122 股。McLean Asset Management Corp 在第二季度将其在默克公司的股份增加了 3.7%。McLean Asset Management Corp 现在拥有 3,543 股该公司的股票，价值 292,000 美元，此前在上个季度增持了 125 股。Cora Capital Advisors LLC 在第二季度将其在默克公司的股份增加了 2.4%。Cora Capital Advisors LLC 现在拥有 5,343 股该公司的股票，价值 423,000 美元，此前在上个季度增持了 125 股。Saiph Capital LLC 在第一季度将其在默克公司的股份增加了 3.7%。Saiph Capital LLC 现在拥有 3,565 股该公司的股票，价值 320,000 美元，此前在上个季度增持了 128 股。最后，Physician Wealth Advisors Inc. 在第二季度将其在默克公司的股份增加了 2.9%。Physician Wealth Advisors Inc. 现在拥有 4,587 股该公司的股票，价值 363,000 美元，此前在上个季度增持了 128 股。对冲基金和其他机构投资者持有该公司 76.07% 的股票。</p>
</div><h2>Merck &amp; Co., Inc. Stock Performance</h2>
<div class="lb-trans"><h2>默克公司股票表现</h2>
</div><p>NYSE:MRK opened at $86.34 on Friday. The company has a fifty day simple moving average of $84.59 and a two-hundred day simple moving average of $82.04. The company has a quick ratio of 1.17, a current ratio of 1.42 and a debt-to-equity ratio of 0.69. Merck &amp; Co., Inc. has a 52 week low of $73.31 and a 52 week high of $105.07. The company has a market cap of $215.66 billion, a price-to-earnings ratio of 13.30, a price-to-earnings-growth ratio of 0.95 and a beta of 0.34.</p>
<div class="lb-trans"><p>NYSE:MRK 周五开盘价为 86.34 美元。该公司的 50 日简单移动平均线为 84.59 美元，200 日简单移动平均线为 82.04 美元。该公司的速动比率为 1.17，流动比率为 1.42，债务与股本比率为 0.69。默克公司的 52 周低点为 73.31 美元，52 周高点为 105.07 美元。该公司的市值为 2156.6 亿美元，市盈率为 13.30，市盈增长比率为 0.95，贝塔值为 0.34。</p>
</div><ul>
<li>5 Healthcare Plays Powering the Sector’s Big Comeback</li>
</ul>
<div class="lb-trans"><ul>
<li>5 个医疗保健股票推动该行业的大反弹</li>
</ul>
</div><p>Merck &amp; Co., Inc. (NYSE:MRK - Get Free Report) last announced its quarterly earnings data on Thursday, October 30th. The company reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.36 by $0.22. The business had revenue of $17.28 billion during the quarter, compared to analysts' expectations of $17 billion. Merck &amp; Co., Inc. had a return on equity of 41.05% and a net margin of 25.79%.The business's quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.57 EPS. Merck &amp; Co., Inc. has set its FY 2025 guidance at 8.930-8.980 EPS. As a group, equities analysts anticipate that Merck &amp; Co., Inc. will post 9.01 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>默克公司（NYSE:MRK - 获取免费报告）最近于 10 月 30 日（星期四）公布了季度财报。该公司报告每股收益（EPS）为 2.58 美元，超出市场共识预期的 2.36 美元，超出幅度为 0.22 美元。该公司在季度内的收入为 172.8 亿美元，而分析师预期为 170 亿美元。默克公司的股本回报率为 41.05%，净利润率为 25.79%。该公司的季度收入较去年同期增长了 3.7%。去年同期，该公司每股收益为 1.57 美元。默克公司已将其 2025 财年的指导目标设定为 8.930-8.980 每股收益。整体来看，股票分析师预计默克公司在当前财年将发布 9.01 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of research firms have weighed in on MRK. Wells Fargo &amp; Company lowered their price objective on Merck &amp; Co., Inc. from $97.00 to $90.00 and set an &#34;equal weight&#34; rating on the stock in a research note on Wednesday, July 30th. Wall Street Zen raised shares of Merck &amp; Co., Inc. from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Saturday. Citigroup initiated coverage on shares of Merck &amp; Co., Inc. in a report on Monday, October 13th. They issued a &#34;neutral&#34; rating and a $95.00 price objective for the company. Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of Merck &amp; Co., Inc. in a research report on Wednesday, October 8th. Finally, Berenberg Bank downgraded shares of Merck &amp; Co., Inc. from a &#34;buy&#34; rating to a &#34;hold&#34; rating and reduced their target price for the stock from $100.00 to $90.00 in a research note on Wednesday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of &#34;Hold&#34; and an average target price of $104.47.</p>
<div class="lb-trans"><p>多家研究公司对 MRK 进行了评估。富国银行将默克公司的目标价从 97.00 美元下调至 90.00 美元，并在 7 月 30 日的研究报告中对该股票给予了 “持平” 的评级。Wall Street Zen 在周六的研究报告中将默克公司的股票评级从 “持有” 上调至 “强力买入”。花旗集团在 10 月 13 日的报告中对默克公司的股票进行了覆盖，给予 “中性” 评级，目标价为 95.00 美元。Weiss Ratings 在 10 月 8 日的研究报告中重申了对默克公司的 “持有（c-）” 评级。最后，Berenberg Bank 在 9 月 17 日的研究报告中将默克公司的股票评级从 “买入” 下调至 “持有”，并将目标价从 100.00 美元下调至 90.00 美元。一位股票研究分析师对该股票给予了强力买入评级，五位给予买入评级，十三位给予持有评级，一位给予卖出评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，平均目标价为 104.47 美元。</p>
</div><ul>
<li>As the Market Rotates, This Healthcare ETF Is Leading the Way</li>
</ul>
<div class="lb-trans"><ul>
<li>随着市场轮动，这只医疗保健 ETF 引领潮流</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Report on MRK</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 MRK 股票报告</strong></p>
</div><h2>Insider Buying and Selling at Merck &amp; Co., Inc.</h2>
<div class="lb-trans"><h2>默克公司的内部买卖情况</h2>
</div><p>In other news, EVP David Michael Williams sold 8,614 shares of the firm's stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $83.59, for a total value of $720,044.26. Following the sale, the executive vice president directly owned 24,578 shares in the company, valued at approximately $2,054,475.02. This trade represents a 25.95% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Insiders own 0.13% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，执行副总裁 David Michael Williams 于 11 月 3 日（星期一）出售了 8,614 股该公司的股票。股票以平均价格 83.59 美元出售，总价值为 720,044.26 美元。出售后，该执行副总裁直接持有该公司 24,578 股股票，价值约为 2,054,475.02 美元。此次交易代表其持股减少了 25.95%。该交易已在向证券交易委员会提交的文件中披露，相关文件可通过此链接访问。内部人士持有该公司 0.13% 的股票。</p>
</div><h2>Merck &amp; Co., Inc. Company Profile</h2>
<div class="lb-trans"><h2>默克公司公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Merck &amp; Co, Inc is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.</p>
<div class="lb-trans"><p>默克公司是一家医疗保健公司，提供通过处方药、疫苗、生物治疗、动物健康和消费者护理产品的健康解决方案。它通过以下几个部门运营：制药、动物健康和其他。制药部门包括人类健康药品和疫苗产品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Merck &amp; Co., Inc.</li>
<li>3 Small Caps With Big Return Potential</li>
<li>OpenAI's Restructuring Sets up What Could Be the Biggest IPO Ever</li>
<li>How is Compound Interest Calculated?</li>
<li>2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail</li>
<li>What is a Special Dividend?</li>
<li>CrowdStrike Partners With CoreWeave But Investors Sell the News</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是默克公司。</li>
<li>三只具有高回报潜力的小型股</li>
<li>OpenAI 的重组可能会成为有史以来最大的 IPO</li>
<li>复利是如何计算的？</li>
<li>两只美国政府不希望失败的稀土股票</li>
<li>什么是特别股息？</li>
<li>CrowdStrike 与 CoreWeave 合作，但投资者抛售了消息</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1SSw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MRK"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Merck &amp; Co., Inc. Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在默克公司吗？</h2>
</div><p>Before you consider Merck &amp; Co., Inc., you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑默克公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck &amp; Co., Inc. wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而默克公司并不在名单上。</p>
</div><p>While Merck &amp; Co., Inc. currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然默克公司目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Modera Wealth Management LLC 出售了默克公司 $MRK 的股票